Imara M&A

Leadership Team with Broad Range of Experience and Success World-Renowned Chemists ● Primarily or co-invented over 20 product candidates that have advanced to clinical trials Precision Oncology and Kinase Inhibitor Experts Led or been involved with the discovery, development, or commercialization of over 60 kinase inhibitor programs Leaders with a Track Record of Success ● Significant experience building and/or leading research, development, and commercial operations FDA-Approved Drugs Co-Invented by Enliven Chemists ●OOD MEKTOVI (binimetinib) 15 mg tablets Ⓡ "TUKYSA tucatinib 50 mg 150 mg tablets Koselugo (selumetinib) 10 mg & 25 mg capsules ✔ Retevmo™ selpercatinib capsules 40 mg-80 mg 7

View entire presentation